Tower Research Capital LLC (TRC)
Position in ENTA — Enanta Pharmaceuticals Inc
CIK 1533421
NEW YORK, NY
Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$59,449
+$48,079 QoQ
Shares Held
4,707
+552.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tower Research Capital LLC (TRC) holds $67,054,823 across 440 Biotechnology names. ENTA ranks #143 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
12,112 | $8,844,787 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,904 | $6,208,692 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,378 | $3,382,617 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,627 | $3,185,285 | |
| 5 | INSM |
INSMED Inc
|
15,410 | $2,519,843 | |
| 6 | LKFT |
Lakefront Biotherapeutics NV
|
66,536 | $1,996,080 | |
| 7 | MRNA |
Moderna, Inc.
|
33,728 | $1,713,382 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
14,349 | $1,065,556 |
All Filings in ENTA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,449 | 4,707 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,370 | 721 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $22,443 | 1,875 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $37,958 | 5,021 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $12,337 | 2,235 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $41,411 | 7,202 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $51,054 | 4,928 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $36,640 | 2,825 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $26,486 | 1,517 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $61,173 | 6,501 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $69,521 | 6,224 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $43,356 | 2,026 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $45,494 | 1,125 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $15,584 | 335 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $318,741 | 6,145 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $577,450 | 12,216 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $756,500 | 10,628 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $227,705 | 3,045 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $78,511 | 1,382 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $61,217 | 1,391 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $83,449 | 1,692 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $38,732 | 920 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $60,932 | 1,331 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $151,483 | 3,017 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||